Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline
CYP1A2 protein mutant form results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline; CYP1A2 results in increased metabolism of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline
[CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline; CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-3,4-dimethylimidazo(4,5-f)quinoline; oltipraz inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline]
